Citigroup Inc. and JPMorgan Chase & Co. will provide debt finance to a $1.97 billion buyout of the medical technology company Immucor by TPG Capital.
Processing Content
The Norcross, Ga., company agreed to be taken private in a deal that will give its shareholders $27 per share in cash.
The buyout has a go-shop period until Aug. 15, and the company expects to close the deal before the end of the year.
Immucor announced the buyout agreement Tuesday and said that TPG's offering price represented a 30.2% premium over the July 1 closing price of its stock. A TPG spokeswoman did not comment. Representatives from Immucor, Citigroup and JPMorgan Chase were not immediately available. - Matthew Sheahan
